|
|
1.
|
Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus. MedStar authors:
Year: 2017
Citation: - Clinical Transplantation. 31(5), 2017 May
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Hassan M, Lalos A, Liriano-Ward L, Morales AL, Nair V, Sang M, Satoskar R, Schiano T, Smith C, Tierney A
|
|
|
2.
|
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. MedStar authors:
Citation: - New England Journal of Medicine. 373(8):714-25, 2015 Aug 20.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Infectious Diseases
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Ackerman P, ALLY-2 Investigators, Dieterich D, Dretler R, Fishbein D, Gathe JC Jr, Henn S, Hinestrosa F, Hughes E, Huynh C, Liu Z, Luetkemeyer A, McDonald C, McPhee F, Mills A, Morgan TR, Noviello S, Overton ET, Ramgopal M, Rashbaum B, Ray G, Ruane PJ, Scarsella A, Sherman KE, Sulkowski MS, Wyles DL, Yin PD, Yozviak J
|
